Abstract:Objective To study the expression and clinical significance of human mammoglobin (hMAM) mRNA and CD44V6 mRNA, and to evaluate the possibility of hMAM mRNA and CD44V6 mRNA as a tumor marker of micrometastasis in breast cancer. Methods Expressions of hMAM mRNA and CD44V6 mRNA were detected in samples of breast cancer and adjacent non-tumoral tissues, benign breast tumor and in peripheral blood from patients with breast cancer and breast benign lesions, and healthy volunteers by nested reverse transcription polymerase chain reaction (nested-RT-PCR), and other cancers (including gastric carcinomas,colorectal carcinomas, esophageal carcinomas, lung carcinomas, and ovary carcinomas) were analyzed for hMAM-mRNA expression by nested-RT-PCR method. Results The positive rates of hMAM mRNA were 96. 72%, 96. 72% and 93. 75% in breast cancer, corresponding normal tissues and breast benign tumor, there was no significant difference from them (P0. 05). hMAM mRNA was not expressed in other cancers. The expression of CD44V6 mRNA was significantly higher than that of adjacent non-tumoral tissues and benign breast tumor. The positive expression rate of hMAM mRNA was 45. 90% in peripheral blood from patients with breast cancer, and the positive rate of hMAM mRNA in peripheral blood of breast cancer patients with stage Ⅳ was significantly higher than those patients with stage Ⅰ ,Ⅱ and Ⅲ (P 0. 05). No hMAM mRNA expression was found in peripheral blood of patients with breast benign lesions or healthy volunteers. The positive expression of CD44V6 mRNA was 83. 61%, 81. 25% and 80. 00% in peripheral blood of patients with breast cancer, breast benign lesions, and healthy volunteers, respectively. No significant difference was found among three groups(P 0. 05). Conclusion hMAM mRNA is specific expression in breast tissue, and the positive expression of hMAM mRNA in peripheral blood might predict hematogenous metastatic spreading of tumor cells, and hMAM mRNA may be potential biological marker for detecting breast cancer micrometastasis. CD44V6 mRNA as a marker of mammary carcinoma cells in peripheral blood is lack of specificity.

Detection of SBEM-mRNA level in peripheral blood of patients with breast cancer and its clinical significance

Detection of SBEM-mRNA in Peripheral Blood of Patients with Breast Cancer and Its Clinical Significance

[Expression of Small Breast Epithelial Mucin Mrna in Peripheral Blood of Breast Cancer Patients and Its Clinical Significance].

Correlation between expression of c-erbB2 and the micrometastases in peripheral blood in breast cancer

The Detection of Micrometastases in the Peripheral Blood of Patients with Breast Cancer for Hsbem Mrna and CD44V6 Mrna

Clinical significance of detecting CEAmRNA,CEA and VEGF in peripheral blood on diagnosing the micrometastasis of malignant tumors

[Detection of CK19 and CEA mRNA expression for the diagnosis of peripheral blood micrometastases in patients with non-small cell lung cancer].

Research on the Relationship of Mrna Expressions CEA,Survivin,MMP-2 and TIMP-2 in Peripheral Blood with Breast Carcinoma

Significance of Peripheral Blood CEA mRNA and livin mRNA in Combined Detection of Micro Metastases in Colorectal Cancer Patients

Sensitive and Specific Detection of Micrometastasis of Hepatic Carcinoma in Peripheral Blood by Immunomagnetic Nanobeads Polymerase Chain Reaction

Expressions of Hmam Mrna and CD44V6 Mrna in Breast Cancer

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-polymerase Chain Reaction in Patients with Breast Cancer

Detection and Clinicopathologic Significance of CK20,CK19,CEA Mrna in Peripheral Blood from Patients with Esophageal Cancer

Detection of micrometastasis in the bone marrow of patients with breast cancer

[Mammaglobin Mrna Measurement in the Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients].

Detection of CEA Mrna-Positive Circulating Tumor Cells in Patients with Early Breast Cancer and Its Clinical Sig-nificance

Detection of Micrometastasis in the Bone Marrow of Patients with Esophageal Carcinomas and Its Clinical Implications

Detection of micrometastasis in sentinel lymph nodes of breast cancer using RT-PCR

CEA Mrna Expression in Peripheral Blood from Breast Cancer Patients and Prediction of Metastasis

Multipoint Quantification of Multimarker Genes in Peripheral Blood and Micrometastasis Characteristic in Peri-Operative Esophageal Cancer Patients

Molecular Detection of Disseminated Tumor Cells in the Peripheral Blood of Patients with Gastric Cancer: Evaluation of Their Prognostic Significance